BOSTON BIOPHARMA Trademark

Trademark Overview

On Friday, November 21, 2014, a trademark application was filed for BOSTON BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the BOSTON BIOPHARMA trademark a serial number of 86461232. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, February 1, 2021. This trademark is owned by Boston Biopharma, Inc. The BOSTON BIOPHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Consultation in the field of pharmaceutical research and development

General Information

Serial Number86461232
Word MarkBOSTON BIOPHARMA
Filing DateFriday, November 21, 2014
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, February 1, 2021
Registration Number4798528
Registration DateTuesday, August 25, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 9, 2015

Trademark Statements

Description of MarkThe mark consists of an outline of a butterfly next to the words "Boston Biopharma".
Pseudo MarkBOSTON BIO PHARMA
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"BOSTON BIOPHARMA"
Goods and ServicesPharmaceutical research and development; Consultation in the field of pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, November 29, 2014
Primary Code042
First Use Anywhere DateTuesday, January 1, 2013
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameBOSTON BIOPHARMA INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressALPHARETTA, GA 30009
Party NameBOSTON BIOPHARMA HOLDING, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressALPHARETTA, GA 30009
Party NameBoston Biopharma, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30009
Party NameBoston Biopharma, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, DE 19711
Party NameBoston Biopharma, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, DE 19711

Trademark Events

Event DateEvent Description
Tuesday, November 25, 2014NEW APPLICATION ENTERED
Saturday, November 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 2, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, March 11, 2015ASSIGNED TO EXAMINER
Wednesday, March 18, 2015NON-FINAL ACTION WRITTEN
Wednesday, March 18, 2015NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 6, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 7, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 7, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, April 7, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 7, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, April 7, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 1, 2015ASSIGNED TO LIE
Monday, May 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 20, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 9, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 9, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 25, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, September 15, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 15, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 1, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 14, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 25, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 15, 2020TEAS SECTION 8 RECEIVED
Tuesday, November 24, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 2, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, December 2, 2020POST REGISTRATION ACTION MAILED - SEC. 8
Monday, February 1, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, February 1, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sunday, August 25, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, November 13, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

biopharma boston pharmaceutical development research field consultation